Authors:
Liqin Liu Department of Biological Science and Engineering, School of Chemical and Biological Engineering, University of Science and Technology Beijing, 30th Xueyuan Road, Haidian District, Beijing, 100083 People’s Republic of China

Search for other papers by Liqin Liu in
Current site
Google Scholar
PubMed
Close
,
Min Zhang Department of Biological Science and Engineering, School of Chemical and Biological Engineering, University of Science and Technology Beijing, 30th Xueyuan Road, Haidian District, Beijing, 100083 People’s Republic of China

Search for other papers by Min Zhang in
Current site
Google Scholar
PubMed
Close
,
Guangrong Zhong Department of Biological Science and Engineering, School of Chemical and Biological Engineering, University of Science and Technology Beijing, 30th Xueyuan Road, Haidian District, Beijing, 100083 People’s Republic of China

Search for other papers by Guangrong Zhong in
Current site
Google Scholar
PubMed
Close
, and
Xuebin Wang Key Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875 People’s Republic of China

Search for other papers by Xuebin Wang in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

A conjugate of 6-hydrazinopyridine-3-carboxylic acid (HYNIC) with the amino analogue of metronidazole (MN) was synthesized through a multiple-step reaction. HYNIC-MN could be labeled easily and efficiently with 99mTc using N-(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)glycine (tricine) and ethylenediamine -N,N′-diacetic acid (EDDA) as coligands to form the 99mTc–HYNIC–MN complex in high yield (>95%). Its partition coefficient indicated that it was a good hydrophilic complex. The tumor cell experiment showed that the 99mTc–HYNIC–MN complex had a certain hypoxic selectivity. The biodistribution studies of 99mTc–HYNIC–MN in Kunming mice bearing S180 tumor showed a favorable tissue distribution profile with high tumor uptake, and low or negligible accumulation in non-target organs, suggesting 99mTc–HYNIC–MN would be a novel potential tumor hypoxia imaging agent.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Nov 2024 8 0 0
Dec 2024 6 0 0
Jan 2025 16 0 0
Feb 2025 11 0 0
Mar 2025 15 0 0
Apr 2025 6 0 0
May 2025 0 0 0